Cytokinetics
CYTK
CYTK
262 hedge funds and large institutions have $4.05B invested in Cytokinetics in 2022 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 103 increasing their positions, 74 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% more capital invested
Capital invested by funds: $3.4B → $4.05B (+$648M)
11.03% more ownership
Funds ownership: 112.59% → 123.61% (+11%)
9% more funds holding
Funds holding: 240 → 262 (+22)
Holders
262
Holding in Top 10
12
Calls
$33.9M
Puts
$5.95M
Top Buyers
| 1 | +$176M | |
| 2 | +$102M | |
| 3 | +$68.3M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$53.2M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$29.5M |
Top Sellers
| 1 | -$64.5M | |
| 2 | -$36.3M | |
| 3 | -$27.6M | |
| 4 |
HM
HealthCor Management
New York
|
-$26.1M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$14.2M |